Importantly, the identification of potential compensatory processes in male Cln3-/- mice in the current study introduces a novel avenue for therapeutic discovery aimed at preserving or restoring auditory function in Batten disease. Here, CLN3 is linked to juvenile neuronal ceroid lipofuscinosis.